In patients with OSA, alterations in FFA metabolism may be potentiated by exposure to intermittent hypoxia and further compounded by the presence of obesity to have a profound effect on adipose tissue and whole-body insulin sensitivity (Ryan, 2017). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.